P911 — Dr Ing hc F Porsche AG Balance Sheet
0.000.00%
- €42.73bn
- €41.87bn
- €40.08bn
- 66
- 79
- 58
- 81
Annual balance sheet for Dr Ing hc F Porsche AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 7,868 | 10,886 | 10,717 | 9,025 | 9,151 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2,972 | 3,014 | 3,621 | 4,432 | 4,573 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 15,096 | 18,552 | 20,154 | 20,040 | 20,288 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 12,309 | 12,717 | 12,778 | 13,584 | 15,441 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 45,491 | 51,382 | 47,642 | 50,447 | 53,527 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 11,285 | 13,079 | 16,579 | 13,567 | 14,343 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 25,272 | 28,455 | 30,615 | 28,780 | 30,484 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 20,219 | 22,927 | 17,027 | 21,667 | 23,043 |
| Total Liabilities & Shareholders' Equity | 45,491 | 51,382 | 47,642 | 50,447 | 53,527 |
| Total Common Shares Outstanding |